EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Efficacy of beta-blocker agents on clinical outcomes in patients with thoracic aortic aneurysm: A systematic review and meta-analysis of randomized controlled trials

Lokman H Tanriverdi, Annie Barrett, Asanish Kalyanasundaram, Mohammad A Zafar, Bulat A Ziganshin, John A Elefteriades

Vascular Pharmacology · 2025-06 · 159 · 107494

DOI: 10.1016/j.vph.2025.107494 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Vascular Pharmacology, 2025-06. Verfasst von Lokman H Tanriverdi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, İnönü University Faculty of Medicine, Malatya, Türkiye.; Aortic Institute at Yale-New Haven, Yale School of Medic…. Hauptthemen laut MEDLINE: Aortic Aneurysm, Thoracic, Adrenergic beta-Antagonists. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Studies investigating the efficacy of β-blocker agents for patients with thoracic aortic aneurysm (TAA) have produced heterogeneous and conflicting results. We assess the effects of β-blockers on clinical outcomes in patients with TAA. METHODS: A systematic literature search was performed through Ovid MEDLINE, EMBASE, Web of Science, Pubmed and Cochrane CENTRAL, all from inception to April 30, 2024. Randomized controlled trials (RCTs) exploring the effect of β-blocker agents in patients with TAA were considered for inclusion, with no population restriction. Inverse variance-weighted random-effects model was used. The overall risk of bias assessment was conducted by Cochrane Risk of Bias 2 tool. The primary outcome was aortic events during follow-up. RESULTS: We included a total of 161 patients with TAA (mean age, 27.6 years; 80 [49.7 %] male, mean follow-up 6.7 years) in 4 RCTs. The pooled risk ratio in the β-blocker arm for aortic events was 0.74 [95 % CI (0.20; 2.71), I2: 0 %, p = 0.64, low certainty of evidence (CoE)] when compared to placebo or no treatment in patients with TAA. The pooled risk ratios for aortic dissection or death (all-cause mortality) or in the β-blocker arm were 0.45 (95 % CI (0.10; 1.98), I2: 0 %, p = 0.29, low CoE) and 0.58 (95 % CI (0.15; 2.24), I2: 0 %, p = 0.43, low CoE), respectively. The risks of aortic dissection, rupture, or death were comparable, regardless of agent, disease, and age. CONCLUSION: We found no evidence of benefit from β-blocker treatment for patients with TAA. More robust RCTs are needed to establish evidence-based recommendations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Aneurysm, ThoracicAdrenergic beta-AntagonistsHumansRandomized Controlled Trials as TopicTreatment OutcomeMaleFemaleRisk FactorsAdultRisk AssessmentTime FactorsMiddle AgedYoung Adult

Stichwörter der Autor:innen

AtenololCeliprololEhler-Danlos syndromeMarfan syndromePropranololThoracic aortic aneurysmbeta-blockers

Substanzen

Adrenergic beta-Antagonists

Autor:innen und Institutionen

  • Department of Medical Pharmacology, İnönü University Faculty of Medicine, Malatya, Türkiye.; Aortic Institute at Yale-New Haven, Yale School of Medicine Department of Surgery, New Haven, CT, United States.
  • Aortic Institute at Yale-New Haven, Yale School of Medicine Department of Surgery, New Haven, CT, United States.
  • Aortic Institute at Yale-New Haven, Yale School of Medicine Department of Surgery, New Haven, CT, United States.. Electronic address: john.elefteriades@yale.edu.

Zitieren

APA

Tanriverdi, L. H., Barrett, A., Kalyanasundaram, A., Zafar, M. A., Ziganshin, B. A., & Elefteriades, J. A. (2025). Efficacy of beta-blocker agents on clinical outcomes in patients with thoracic aortic aneurysm: A systematic review and meta-analysis of randomized controlled trials. Vascular Pharmacology, 159, 107494. https://doi.org/10.1016/j.vph.2025.107494

Vancouver

Tanriverdi LH, Barrett A, Kalyanasundaram A, Zafar MA, Ziganshin BA, Elefteriades JA. Efficacy of beta-blocker agents on clinical outcomes in patients with thoracic aortic aneurysm: A systematic review and meta-analysis of randomized controlled trials. Vascular Pharmacology. 2025;159:107494. doi:10.1016/j.vph.2025.107494

BibTeX
@article{Tanriverdi2025,
  author = {Tanriverdi, Lokman H and Barrett, Annie and Kalyanasundaram, Asanish and Zafar, Mohammad A and Ziganshin, Bulat A and Elefteriades, John A},
  title = {Efficacy of beta-blocker agents on clinical outcomes in patients with thoracic aortic aneurysm: A systematic review and meta-analysis of randomized controlled trials},
  journal = {Vascular Pharmacology},
  year = {2025},
  volume = {159},
  pages = {107494},
  doi = {10.1016/j.vph.2025.107494}
}
Kostenlos starten →